Safety factors and establishment of acceptable daily intakes.

The acceptable daily intake (ADI) of food additives and other foreign compounds is derived usually by the application of a 100-fold safety factor to the 'no observable adverse effect' level in animal experiments. This safety factor is recognized as comprising two 10-fold factors to allow for possible differences between animals and humans, and for possible differences between individual humans. This paper reviews the adequacy of these safety factors in relation to published data on inter-species and inter-individual differences in both the kinetics and dynamics of foreign compounds. Although the 100-fold factor is reasonable, situations can be envisaged where the scientific data base indicates that considerably higher or lower factors would be more appropriate. A scheme is proposed that would allow structured flexibility to be available in the choice of safety factor to be used in the regulation of foreign compounds.

[1]  A. Renwick,et al.  The tissue distribution and pharmacokinetics of saccharin in the rat. , 1980, Toxicology and applied pharmacology.

[2]  F. Lu,et al.  Acceptable daily intake: inception, evolution, and application. , 1988, Regulatory toxicology and pharmacology : RTP.

[3]  G. Levy,et al.  Comparative pharmacokinetics of salicylate elimination in man and rats. , 1966, The Journal of pharmacology and experimental therapeutics.

[4]  M. Schulz,et al.  On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  J. Mordenti,et al.  Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data. , 1985, Journal of pharmaceutical sciences.

[6]  C. Walker.  Species differences in microsomal monooxygenase activity and their relationship to biological half-lives. , 1978, Drug metabolism reviews.

[7]  E. Calabrese,et al.  The effect of ascorbic acid on copper-induced oxidative changes in the erythrocytes of rats, sheep, and normal humans. , 1983, Regulatory toxicology and pharmacology : RTP.

[8]  G. Siest,et al.  Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[10]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[11]  A G Renwick,et al.  Role of the gut flora in the reduction of sulfinpyrazone in humans. , 1984, The Journal of pharmacology and experimental therapeutics.

[12]  H. W. Ruelius.  Extrapolation from animals to man: predictions, pitfalls and perspectives. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  M. Brodie,et al.  Tissue and species differences in enzymes of epoxide metabolism. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  D. H. Hutson,et al.  Detoxification of the organophosphorus insecticide chlorfenvinphos by rat, rabbit and human liver enzymes. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  S. Garattini.  Toxic effects of chemicals: difficulties in extrapolating data from animals to man. , 1985, Critical reviews in toxicology.

[16]  A. Renwick,et al.  The disposition of saccharin in animals and man--a review. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  A. Renwick,et al.  The pharmacokinetics of saccharin in man. , 1981, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  H. Vainio,et al.  Pharmacokinetics and metabolism of styrene , 1984 .

[19]  J. Caldwell,et al.  The metabolism of aspirin in man: a population study. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  J. Idle,et al.  The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  J. De Keyser,et al.  High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. , 1989, Biochemical pharmacology.

[22]  A. Hayes.  Principles and methods of toxicology , 1982 .

[23]  A. Renwick,et al.  The fate of cyclamate in man and other species. , 1972, The Biochemical journal.

[24]  G. Siest,et al.  Induction of plasma and tissue enzymes by drugs: significance in toxicological studies. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  E. Calabrese,et al.  The effect of ascorbic acid on nitrite-induced methemoglobin formation in rats, sheep, and normal human erythrocytes. , 1983, Regulatory toxicology and pharmacology : RTP.

[26]  A. Yacobi,et al.  Pharmacokinetics in chronic animal toxicity studies. , 1982, Drug metabolism reviews.

[27]  A G Renwick,et al.  The pharmacokinetics of oral nifedipine--a population study. , 1988, British journal of clinical pharmacology.

[28]  A. Renwick,et al.  The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice. , 1989, Toxicology and applied pharmacology.

[29]  A. Boobis,et al.  Human cytochromes P-450. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.